New discovery being dubbed as a 'super antibody'

By Admin
A ‘super antibody which fights against all types of influenza A has been discovered by a team of Swiss and British researchers. The scientists ar...

A ‘super antibody’ which fights against all types of influenza A has been discovered by a team of Swiss and British researchers.

The scientists are now hopeful the finding could lead to the development of an emergency treatment for the virus and revolutionise flu vaccines.

In the current situation, flu vaccine makers have to adapt their jabs every year to make sure they are able to combat the seasonal flu strains.

However, the new development looks like it could act as a universal vaccine which has the ability to fight many types of the flu virus.


To read the latest edition of Healthcare Global, click here

After looking at 100,000 cell samples, the scientists were able to identify an antibody which effectively targeted the haemagglutinin protein which is found on the surface of all influenza A viruses.

Sir John Skehel, a Medical Research Council scientist who worked on the project, said in a media interview: “We've tried every subtype of influenza A and it interacts with them all.

“We eventually hope it can be used as a therapy by injecting the antibody to stop the infection.”

Meanwhile, the director of the Institute for Research in Biomedicine in Switzerland, Antonio Lanzavecchia, stated: “As the first and only antibody which targets all known subtypes of the influenza A virus, FI6 represents an important new treatment option.”

The findings of the experiments have been published in the Science Express journal. 


Featured Articles

Digital healthcare platform Balanced supports healthy ageing

10,000 people turn 65 in the USA each day. Digital healthcare platform Balanced wants to help them better manage healthy ageing, says CEO Katie Reed

TrueBinding’s antibody drugs fight Alzheimer’s Disease

Dongxu Sun, CEO at TrueBinding, shares how its research & antibody drug development is fighting illnesses such as Alzheimer’s Disease, stroke & more

Cardinal Health’s clinically integrated pharma supply chain

Peter J. Siavelis, SVP & General Manager, Health System & Provider Distribution & Services at Cardinal Health, discusses the integrated pharma supply chain

Healthcare Digital news roundup: digital healthcare & AI

Digital Healthcare

Hospitals must embrace IoMT device security


Mental health support for working women and mothers

Digital Healthcare